GTx (United States)
GTx, Inc. was a pharmaceutical company working on drugs in the selective estrogen receptor modulator and selective androgen receptor modulator classes. Its drugs in development included enobosarm and GTx-758. The company was founded in Memphis in 1997 by Mitch Steiner and Marc S. Hanover. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for GTx (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
30%
Total
Publications
26K
Total Open
Publications
7.7K
Total
Citations
992K
Open Access
Percentage
30%
Total
Publications
26K
Total Open
Publications
7.7K
Total
Citations
992K
Breakdown
Publisher Open
13%
Both
7%
Other Platform Open
10%
Closed
70%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 8%
419
Hybrid 25%
1.3K
No Guarantees 67%
3.5K
Other Platform Open
Domain 74%
3.1K
Institution 29%
1.3K
Other Internet 7%
303
Preprint 4%
170
Public 4%
169
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 3.1K |
Europe PMC | Domain | 2.2K |
Semantic Scholar | Public | 133 |
Research Square | Preprint | 103 |
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System | Institution | 103 |
California Digital Library - eScholarship | Other Internet | 99 |
University of California - eScholarship University of California | Institution | 92 |
University College London - UCL Discovery | Institution | 79 |
RePEc: Research Papers in Economics - RePEc | Preprint | 62 |
University of North Carolina at Chapel Hill - Carolina Digital Repository | Institution | 59 |